In Vitro testing of Bilastine For Transporter Mediated Drug-Drug Interactions

被引:0
|
作者
Ganza, Alvaro [1 ]
Ortega, Ignacio [1 ]
Gonzalo, Ana [1 ]
Luisa Lucero, Maria [1 ]
Jahic, Mirza [2 ]
Bednarczyk, Dallas [2 ]
Gedey, Szilvia
Nagy, Zoltan [4 ]
Juhasz, Viktoria [4 ]
Ioja, Eniko [3 ]
机构
[1] Faes Farma, RDi, Vizcaya, Spain
[2] Optivia Biotechnol Inc, Menlo Pk, CA USA
[3] SOLVO Biotechnol, Res & Dev, Szeged, Hungary
[4] SOLVO Biotechnol, R&D, Budaors, Hungary
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:303 / 303
页数:1
相关论文
共 50 条
  • [41] Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
    Manthena V. S. Varma
    Yurong Lai
    Bo Feng
    John Litchfield
    Theunis C. Goosen
    Arthur Bergman
    Pharmaceutical Research, 2012, 29 : 2860 - 2873
  • [42] Using Positron Emission Tomography to Study Transporter-Mediated Drug-Drug Interactions in Tissues
    Wulkersdorfer, B.
    Wanek, T.
    Bauer, M.
    Zeitlinger, M.
    Mueller, M.
    Langer, O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 206 - 213
  • [43] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
    Hanke, Nina
    Gomez-Mantilla, Jose David
    Ishiguro, Naoki
    Stopfer, Peter
    Nock, Valerie
    PHARMACEUTICAL RESEARCH, 2021, 38 (10) : 1645 - 1661
  • [44] Hepatic transporter-mediated pharmacokinetic drug-drug interactions: Recent studies and regulatory recommendations
    Izat, Nihan
    Sahin, Selma
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2021, 42 (2-3) : 45 - 77
  • [45] Transporter-mediated drug-drug interactions: advancement in models, analytical tools, and regulatory perspective
    Jala, Aishwarya
    Ponneganti, Srikanth
    Vishnubhatla, Devi Swetha
    Bhuvanam, Gayathri
    Mekala, Prithvi Raju
    Varghese, Bincy
    Radhakrishnanand, Pullapanthula
    Adela, Ramu
    Murty, Upadhyayula Suryanarayana
    Borkar, Roshan M.
    DRUG METABOLISM REVIEWS, 2021, 53 (03) : 285 - 320
  • [46] Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey
    Kosa, Rachel E.
    Lazzaro, Sarah
    Bi, Yi-an
    Tierney, Brendan
    Gates, Dana
    Modi, Sweta
    Costales, Chester
    Rodrigues, A. David
    Tremaine, Larry M.
    Varma, Manthena V.
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (08) : 1179 - 1189
  • [47] Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
    Manthena V. S. Varma
    Yurong Lai
    Emi Kimoto
    Theunis C. Goosen
    Ayman F. El-Kattan
    Vikas Kumar
    Pharmaceutical Research, 2013, 30 : 1188 - 1199
  • [48] Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
    Hannah Britz
    Nina Hanke
    Mitchell E. Taub
    Ting Wang
    Bhagwat Prasad
    Éric Fernandez
    Peter Stopfer
    Valerie Nock
    Thorsten Lehr
    Pharmaceutical Research, 2020, 37
  • [49] Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
    Kido, Yasuto
    Matsson, Paer
    Giacomini, Kathleen M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4548 - 4558
  • [50] Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologies
    Williamson, Beth
    Riley, Robert J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (12) : 1237 - 1250